2026 Speakers

Todd McDevitt

Vice President, Head of Cell Therapy

Genentech, A Member of the Roche Group

Arvind Natarajan

Senior Vice President, Process and Analytical Development

Iovance Biotherapeutics, Inc.

Craig Malzahn

EVP, Product Development and Chief Technology Officer

Regenxbio

Mayo Pujols

CTO

Kyverna

Nelly Viseux

Vice President, Cell Therapies Development, Manufacturing, Supply & Quality

Regeneron

Robert Hofmeister

Chief Scientific Officer

CREATE Medicines

Silviu Itescu

CEO

Mesoblast

Tadayuki Tanimura

Executive Vice President / Board Member

Cuorips Inc.

Hari Pujar, PhD

Chief Operating Officer

Tessera Therapeutics

Phillip Ramsey

CTO, SVP Technical Operations

Sangamo Therapeutics

Kumar Dhanasekharan, PhD

SVP, Head of Technical Operations

Voyager Therapeutics

Bo Yan, PhD

Senior Director, Analytical Development

Beam Therapeutics

Ratnesh Joshi

Associate Director, Downstream Process Development

Editas Medicine

Shankar Swaminathan, PhD

Team Lead, Drug Product Development, CMC-Tech Ops

Astellas Institute for Regenerative Medicine

Dr. Rajeev Boregowda

Associate Director, Bioassay & Molecular Analytical Development, Genomic Medicine CMC

Sanofi

James Blackwell

President and Principal Consultant

The Windshire Group, LLC

Daniel Friedman

Managing Director

BroadOak Capital

Laura Stoppel

Partner

RA Capital Management

Christian Uhrich

Executive Investment Director

M Ventures

Sebastien Latapie

Partner

AVANT BIO

Khandan Baradaran

Principal

Mill Creek Consulting LLC

Andrew Zydney, Ph.D.

Bayard D. Kunkle Chair, Chemical Engineering

Penn State University

Jared Simons

VP, Manufacturing

Solid Biosciences Inc.

Brian Murphy

VP Cell Process Science

Arcellx

Keenan Bashour

VP, Manufacturing & Process Development

4D Molecular Therapeutics

Rui Tostoes

CTO

ImmuneBridge

Stephen Krause

Executive Director, Analytical Strategy, Cell Therapies Global Quality

Bristol Myers Squibb

Carin Von Kahr

Associate Director, MSAT

AskBio Inc.

Nafees Rahman

Senior Director, Process Development

Nkarta Therapeutics, Inc

Guillaume Cornelis

Senior Director, AD and Global Head of AS&T

Cellectis

Lauren Kelly

Director of Translational Research

Siren Biotechnology

Ryan Schweller

Associate Director, Process Development

AskBio Inc.

Elisaveta Todorova

Associate Director of Process Development and Technology Innovation

TScan Therapeutics

Ronnie Lum

Director, Analytical Technology, Analytical & Quality Control

BlueRock Therapeutics

Kelly Bowen

Senior Scientist, Analytical and Process Development

KSQ Therapeutics, Inc.

Lukas Maloney

Process Development Engineer I

Regeneron

Sha Sha

Senior Scientist

Ultragenyx

Sheila Sharifzad

Development Scientist

Bayer

Madhuresh Sumit

Associate Director, Genomic Medicine CMC

Sanofi

Christopher Bravery

Consulting Regulatory Scientist

Advbiols

Tyler Koop

Vice President, Global Commercial, Cell Therapy

Bristol Myers Squibb

Devyn M. Smith

Chief Executive Officer

Arbor Biotechnologies

Shahrooz Rabizadeh

CEO & Co-Founder

Sagittarius Bio, Inc

Amy Shaw

Head of Process Development

Takeda Pharmaceuticals

Therese Choquette

Chief Technical Officer

Tigen Pharma SA